Polatuzumab vedotin (solution), CAS [[1313206-42-6]]

Catalog Number: MCE-HY-132253A
Article Name: Polatuzumab vedotin (solution), CAS [[1313206-42-6]]
Biozol Catalog Number: MCE-HY-132253A
Supplier Catalog Number: HY-132253A
Alternative Catalog Number: MCE-HY-132253A-1MG,MCE-HY-132253A-10MG,MCE-HY-132253A-5MG
Manufacturer: MedchemExpress
Category: Biochemikalien
Polatuzumab vedotin solution is an antibody-drug conjugate targeting CD79b. It contains a humanized anti-CD79b IgG1 monoclonal antibody linked to monomethyl auristatin E (MMAE), a potent microtubule inhibitor. The antibody portion is Polatuzumab (HY-P99042), and the drug-linker conjugate for ADC is VcMMAE (HY-15575). Polatuzumab vedotin solution has the potential for the research of Large B-cell lymphomas (LBCL)[1].
Molecular Weight: 150000 (average)
Purity: 98.36
CAS Number: [1313206-42-6]
Target: Antibody-Drug Conjugates (ADCs),Transmembrane Glycoprotein
Application Notes: MCE Product type: ADC Related